Companies: 10,795·Total market cap: $144.5T
MediciNova, Inc.

MediciNova, Inc.

MNOVNASDAQHealthcare● Active
$1.30
$-0.01(-0.76%)
Market Cap$63987620
P/E Ratio
52W High$1.96
52W Low$1.17
Overview

MediciNova, Inc.(MNOV)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MNOV · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.23mnov eps ttm · mnov earnings per shareEarnings history
PE Ratio (TTM)mnov pe ratio ttm · mnov price to earningsPE Ratio deep dive
Revenue (TTM)596641.00mnov revenue ttm · mnov annual revenueFull revenue history
Dividend Yield不分红does mnov pay dividends · mnov dividend yieldDividend history
Shares Outstanding49.1Mmnov shares outstanding · mnov floatShares outstanding history
Next EarningsAug 13, 2026Est.mnov earnings date · mnov next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$409657.00
202320242025
medicinova, inc. revenue · mnov revenue 2025
FY 2025Net Income-$12.0M▼ 8.58% YoY
202320242025
medicinova, inc. net income · mnov profit 2025
FY 2025EPS$-0.24▼ 4.35% YoY
202320242025
mnov eps · medicinova, inc. earnings per share 2025
TTM:Revenue: $596641.00Net Income: -$11.7MEPS: $-0.23View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy4 位分析师is mnov a buy · mnov analyst rating
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$1.30Current
$Avg Target
$High
mnov price target · mnov 12 month forecast

合计: 4 · 买入占比: 100.0%

股票表现

完整历史
1D-0.76%
1W-0.76%
1M-7.14%
3M-5.80%
YTD-0.76%
1Y-8.45%
5Y-69.70%

关于 MediciNova, Inc.

CEOYuichi Iwaki
IPO DateDec 8, 2006
Employees13
CountryUS

MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United…

what is medicinova, inc. · mnov stock overview · medicinova, inc. company profile · who is medicinova, inc. ceo · mnov NASDAQ · medicinova, inc. headquarters · medicinova, inc. business segments

关于股票概览与关键数据

MediciNova, Inc.(MNOV)是 Biotechnology 行业的 Healthcare 类公司,于 Dec 8, 2006 在 NASDAQ 上市。截至最近交易日,MNOV 股价为 $1.30,市值约为 $64.0M。过去12个月累计回报 -8.45%,年初至今回报 -0.76%。

根据 4 位华尔街分析师,MediciNova, Inc. 股票共识评级为Buy,12个月平均目标价为 $—。2025 财年 MediciNova, Inc. 营收 $409657.00,净利润 -$12.0M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,MediciNova, Inc.(MNOV)股价为 $1.30,在 NASDAQ 上市,52周区间为 $1.17 – $1.96。

MNOV 最新股价MNOV quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议